Announcement PDF 1 July 2024 Mr Phillip Hains Company Secretary c/- The CFO Solution Level 3, 62 Lygon Street Carlton South VIC 3053 Australia Dear Mr Hains, Equity Derivatives of Point72 Associates, LLC in Radiopharm Theranostics Ltd We refer to Guidance Note 20: Equity Derivatives (GN20) issued by the Australian Takeovers Panel. Terms not defined in this notice have the meaning given to them in GN20. GN20 relevantly provides that the non-disclosure of long positions, including long equity derivative positions, may give rise to unacceptable circumstances. Point72 Asset Management, L.P. (Point72), as investment manager of Point72 Associates, LLC (the Fund), discloses the below information on behalf of the Fund, as at the date of this letter, under GN20. Point72 consents to Radiopharm Theranostics Ltd releasing the information contained in this formal disclosure to the ASX. Please provide confirmation to us once this has been released to the ASX. Iden�ty of the taker: Point72 Associates, LLC Relevant security: Ordinary shares in RADIOPHARM THERANOSTICS LTD Price (including reference price, strike price, op�on price etc as appropriate): Not applicable. Entry date and number of securi�es to which the deriva�ve relates: Total number of securi�es to which deriva�ves relate as at 1 July 2024: [54,029,156 ORDs] Type of deriva�ve (e.g. contract for difference, cash setled put or call op�on): Cash setled equity swap Any material changes to informa�on previously disclosed to the market: No informa�on previously disclosed Relevant interest in the securi�es: None Long equity deriva�ve posi�ons held by the taker and its associates: The Fund has no other associates with a long equity deriva�ve posi�on or relevant interest in the company Short equity deriva�ve posi�ons that offset long posi�ons None Short posi�ons of more than 1% that have been acquired a�er a long posi�on is disclosed, whether by no�ce or substan�al holding no�ce. None Yours sincerely, Vincent Tortorella General Counsel and Chief Compliance Officer Point72 Asset Management, L.P.